Think Research Corporation

TSXV:THNK Voorraadrapport

Marktkapitalisatie: CA$24.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Think Research Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Think Research's earnings have been declining at an average annual rate of -12.5%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 39.7% per year.

Belangrijke informatie

-12.5%

Groei van de winst

11.9%

Groei van de winst per aandeel

Healthcare Services Groei van de industrie-3.9%
Inkomstengroei39.7%
Rendement op eigen vermogen-54.8%
Nettomarge-18.0%
Laatste winstupdate30 Sep 2023

Recente prestatie-updates uit het verleden

Recent updates

Is Think Research (CVE:THNK) Using Debt In A Risky Way?

Feb 10
Is Think Research (CVE:THNK) Using Debt In A Risky Way?

Little Excitement Around Think Research Corporation's (CVE:THNK) Revenues As Shares Take 28% Pounding

Dec 18
Little Excitement Around Think Research Corporation's (CVE:THNK) Revenues As Shares Take 28% Pounding

Why Investors Shouldn't Be Surprised By Think Research Corporation's (CVE:THNK) 26% Share Price Plunge

Sep 06
Why Investors Shouldn't Be Surprised By Think Research Corporation's (CVE:THNK) 26% Share Price Plunge

Think Research Corporation (CVE:THNK) Shares Could Be 48% Below Their Intrinsic Value Estimate

Feb 28
Think Research Corporation (CVE:THNK) Shares Could Be 48% Below Their Intrinsic Value Estimate

Analysts Have Been Trimming Their Think Research Corporation (CVE:THNK) Price Target After Its Latest Report

Dec 01
Analysts Have Been Trimming Their Think Research Corporation (CVE:THNK) Price Target After Its Latest Report

Analysts Expect Breakeven For Think Research Corporation (CVE:THNK) Before Long

Mar 30
Analysts Expect Breakeven For Think Research Corporation (CVE:THNK) Before Long

Opbrengsten en kosten

Hoe Think Research geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

TSXV:THNK Opbrengsten, kosten en inkomsten (CAD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 2385-15348
30 Jun 2384-18347
31 Mar 2380-23367
31 Dec 2279-26367
30 Sep 2276-28389
30 Jun 2268-32389
31 Mar 2260-30358
31 Dec 2148-29338
30 Sep 2132-35277
30 Jun 2126-24206
31 Mar 2120-22166
31 Dec 2017-18136
30 Sep 2019-10175
30 Jun 2020-11176
30 Sep 1917-13157
30 Sep 1815-12168

Kwaliteitswinsten: THNK is currently unprofitable.

Groeiende winstmarge: THNK is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: THNK is unprofitable, and losses have increased over the past 5 years at a rate of 12.5% per year.

Versnelling van de groei: Unable to compare THNK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: THNK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).


Rendement op eigen vermogen

Hoge ROE: THNK has a negative Return on Equity (-54.78%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden